Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults

Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults

Abstract Background A growing number of in vitro and in vivo studies suggest the application of probiotics as a natural approach to maintaining oral health. This double-blind, randomized controlled trial aimed to evaluate the efficacy of Levilactobacillus brevis CD2 (CNCM I-5566), a multifunctional...

Full description

Saved in:
Bibliographic Details
Main Authors: Serena Altamura, Francesca Lombardi, Francesca Rosaria Augello, Antonella Barone, Mario Giannoni, Benedetta Cinque, Davide Pietropaoli
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Translational Medicine
Subjects:
Probiotics
Levilactobacillus brevis
Oral health
Randomized clinical trial
Clinical salivary parameters
Salivary biomarkers
Online Access:https://doi.org/10.1186/s12967-024-06000-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items